Sort
261,768 grants matching “gene therapy”
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
$1,160,659Josh Levitsky · Northwestern University At Chicago · U01 · FY2021 · AI
Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial
$1,160,639John R Guy · University Of Miami School Of Medicine · U10 · FY2017 · EY
Dynamic State Space Modeling of Cancer Cell Response to Therapy
$1,160,630Garry P Nolan · University Of Southern California · U54 · FY2011 · CA
Epigenetic mechanisms regulating the Igf2/H19 and Kcnq1 locus
$1,160,466Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Identifying novel modes of oncogenic signaling in multiple myeloma
$1,160,441Ryan Young · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$1,160,422Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Childhood Cancer Survivor Study
$1,160,378Leslie L Robison · St. Jude Children'S Research Hospital · U24 · FY2011 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER
$1,160,271Thomas Jefferson University · P01 · FY2003 · CA
Long-Term Neural Determinants of Cardiovascular Diseases
$1,160,260University Of Minnesota Twin Cities · R01 · FY2005 · HL
Dissecting the stress circuits of the paraventricular nucleus of the thalamus
$1,160,221Mario Penzo · National Institute Of Mental Health · ZIA · FY2016 · MH
Development of a potent and selective oral ENPP1 inhibitor for oncology
$1,160,011Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2022 · CA
The Boston Lung Cancer Survival Cohort
$1,159,880David C Christiani · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · CA
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,159,820Jonathan P Schneck · Johns Hopkins University · P41 · FY2023 · EB
A Vaccine for Schistosomiasis, "SchistoShield"
$1,159,786Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2016 · AI
Molecular Pathogenesis Of JC Virus & Progressive Multifocal Leukoencephalopathy
$1,159,687Eugene O. Major · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Tumor selective inhibition of the WNT pathway
$1,159,628Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Cancer cell adaptation to metabolic stress
$1,159,608M. Celeste Simon · University Of Pennsylvania · P01 · FY2015 · CA
Cancer cell adaptation to metabolic stress
$1,159,608M. Celeste Simon · University Of Pennsylvania · P01 · FY2016 · CA
Cancer cell adaptation to metabolic stress
$1,159,608M. Celeste Simon · University Of Pennsylvania · P01 · FY2017 · CA
Unlocking evolutionarily latent immune functions for treating disease
$1,159,520Brenda L. Bass · University Of Utah · R01 · FY2022 · CA
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease
$1,159,340Mitchell J Weiss · St. Jude Children'S Research Hospital · U01 · FY2024 · HL
Development of novel genetic medicine approaches to treat orphan diseases
$1,159,305Martin K. Childers · Kinea Bio, Inc. · R44 · FY2025 · AR
A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders
$1,159,302Anthony D Saleh · Mirecule, Inc. · R44 · FY2024 · NS
Novel Mechanistic Targets of Steroid Hormones in the Brain
$1,159,183Meharvan Singh · University Of North Texas Hlth Sci Ctr · P01 · FY2015 · AG
OPTIMIZE - CCC - Lead Application
$1,159,052Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2013 · HL